IPO - Tivic Health Systems, Inc.

Form Type: S-1

Filing Date: 2025-06-06

Corporate Action: Ipo

Type: New

Accession Number: 000168316825004306

Filing Summary: Tivic Health Systems, Inc. has filed a registration statement under the Securities Act of 1933 to register 8,438,949 shares of its common stock. This includes shares to be issued upon the conversion of Series B Non-Voting Convertible Preferred Stock and shares from the exercise of warrants. The offering is intended to satisfy registration rights granted to the Selling Stockholder, Helena Global Investment Opportunities 1 Ltd. The filing indicates that Tivic has engaged in a securities purchase agreement on April 29, 2025, and will receive proceeds from the sale of shares of Series B Preferred Stock, but will not receive any proceeds from the sale of common stock by the Selling Stockholder. Currently, Tivic’s common stock trades on The Nasdaq under the symbol 'TIVC', with a reported price of $4.15 per share as of June 4, 2025. Tivic is positioned as an emerging growth company and smaller reporting company, subject to reduced reporting requirements.

Form Type: DRS

Filing Date: 2025-05-15

Corporate Action: Ipo

Type: New

Accession Number: 000168316825003732

Filing Summary: On May 15, 2025, Tivic Health Systems, Inc. submitted a draft registration statement on Form S-1, intended to register the offer and resale of up to 8,438,949 shares of common stock by Helena Global Investment Opportunities 1 Ltd., a selling stockholder. The offering includes shares issuable upon conversion of Series B Non-Voting Convertible Preferred Stock and shares issuable upon the exercise of certain warrants. The filing indicates a potential IPO within the outlined guidelines, as the registration statement is yet to be publicly filed and remains confidential. The shares are related to the recently finalized Securities Purchase Agreement from April 29, 2025, at a floor price of $1.294. The prospectus discusses the company’s existing product, ClearUP, its focus on non-invasive medical devices, current clinical research, and a corporate structure categorized under 'emerging growth company' and 'smaller reporting company' classification. The document emphasizes various strategic directions within their product pipeline and investor considerations.

Form Type: S-1

Filing Date: 2025-05-09

Corporate Action: Ipo

Type: New

Accession Number: 000168316825003353

Filing Summary: Tivic Health Systems, Inc. filed a Form S-1 registration statement with the SEC to register the offer and resale of up to 292,523 shares of its common stock, primarily by Mast Hill Fund, L.P. This registration satisfies certain registration rights granted to Mast Hill in connection with an Equity Purchase Agreement signed on March 18, 2025. The issued shares consist of 262,723 shares that may be sold to Mast Hill and 29,800 shares issued as commitment shares. The prospectus indicates that the company will not receive proceeds from the sale of shares by the Selling Stockholder, but it may receive up to $25 million from the issuance of shares under the Purchase Agreement when the registration is effective. Tivic Health's common stock trades on the Nasdaq Capital Market under the symbol 'TIVC,' with the last reported sale price at $4.30 per share as of May 7, 2025. The company is identified as an 'emerging growth company' and 'smaller reporting company' under federal securities laws and has opted for reduced reporting requirements. The document outlines potential risks involved in the offering and provides an overview of company operations, including its FDA-approved device, ClearUP, and ongoing clinical developments in bioelectronic therapies and immunotherapeutics. The filing follows two recent reverse stock splits aimed at maintaining listing requirements.

Form Type: DRSLTR

Filing Date: 2025-05-02

Corporate Action: Ipo

Type: New

Accession Number: 000168316825003083

Filing Summary: Tivic Health Systems, Inc. submitted a confidential draft registration statement on Form S-1 to the Securities and Exchange Commission for nonpublic review. This registration statement is intended for the resale of the company's Common Stock under Section 12(b) of the Securities Exchange Act of 1934. The company has confirmed that it will publicly file the Draft Registration Statement and any nonpublic draft submissions at least two business days prior to any requested effective date.

Form Type: DRS

Filing Date: 2025-05-02

Corporate Action: Ipo

Type: New

Accession Number: 000168316825003085

Filing Summary: On May 2, 2025, Tivic Health Systems, Inc. filed a draft registration statement for the offer and resale of 292,523 shares of common stock under the Securities Act of 1933. This document applies to the selling stockholder, Mast Hill Fund, L.P., who may resell these shares in the market. The transaction is tied to an Equity Purchase Agreement dated March 18, 2025, under which Tivic may issue up to 262,723 shares to Mast Hill and also includes 29,800 commitment shares. The company is not selling any shares and will not receive proceeds from the resale, although it could gather up to $25 million from sales to Mast Hill, once the registration statement is effective. The common stock is trading on the Nasdaq under the symbol 'TIVC', with a last reported price of $4.61 per share as of April 29, 2025. The company describes itself as an emerging growth and smaller reporting company, which enables it to comply with reduced reporting requirements.